Management of the Infant Born to an HIV-1 Infected Mother
- 期刊名称Pediatric Drugs
- 作者Rongkavilit, Chokechai; Mitchell, Charles D.; Nachman, Sharon
- 卷第1卷
- 期第4期
- 印刷ISSN1174-5878
- 文件大小125.79KB
- 发表时间1999-10
- DOI10.2165/00128072-199901040-00008
- 页码325-330
Dramatic response to radiotherapy combined with vemurafenib. Is vemurafenib a radiosensitizer?Barouyr Baroudjian,Lise Boussemart,Emilie Routier… · European Journal of Dermatology · 2014
Synergistic Combination of Novel Tubulin Inhibitor ABI-274 and Vemurafenib Overcomes Vemurafenib Acquired Resistance in BRAFV600E MelanomaWang, J.; Chen, J.; Miller, D. D.; Li, W. · Molecular Cancer Therapeutics · 2014
Vemurafenib and cobimetinib overcome resistance to vemurafenib in <i>BRAF</i> -mutant gangliogliomaTouat, Mehdi; Gratieux, Julie; Condette Auliac, Stephanie; Sejean, Karine; Aldea, Sorin; Savatovsky, Julien; Perkins, Géraldine; Blons, Hélène; Ligon, Keith L.; Idbaih, Ahmed; Hollebecque, Antoine; Gimenez-Roqueplo, Anne-Paule; Laurent-Puig, Pierre; Sanson, Marc; Villa, Chiara; Di Stefano, Anna Luisa · Neurology · 2018
Two cases of successful treatment for severe skin rash induced by vemurafenib following nivolumab therapy without cessation of vemurafenibTsuboi, Satoshi; Yoshino, Koji; Yamaguchi, Kei; Imafuku, Keisuke; Ohara, Kuniaki · The Journal of Dermatology · 2016
Cobimetinib‑/Vemurafenib-assoziierte bilaterale seröse Retinopathie: ein Fallbericht; Cobimetinib/vemurafenib-associated bilateral serous retinopathy: a case report;Kastl, Gregor · Der Ophthalmologe · 2018
Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial dataHopkins, Ashley M; Van Dyk, Madele; Rowland, Andrew; Sorich, Michael J · Pigment Cell & Melanoma Research · 2019
Association of PD-L1 expression with treatment outcomes in patients with <i>BRAF</i> mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenibWongchenko, Matthew J.; Ribas, Antoni; Dréno, Brigitte; Ascierto, Paolo A.; McArthur, Grant A.; Gallo, Jorge D.; Rooney, Isabelle A.; Hsu, Jessie; Koeppen, Hartmut; Yan, Yibing; Larkin, James · Pigment Cell & Melanoma Research · 2017
Aflibercept, ipilimumab, and vemurafenibAu, Angelica Y. · 2012
ErlotinibDean M. Robinson, Gillian M. Keating, Caroline M. Perry · 2005
RopiniroleSusan M. Cheer,Lynne M. Bang,Gillian M. Keating · CNS Drugs · 2004
RasagilineVicki Oldfield, Gillian M. Keating, Caroline M. Perry · 2007
ZiprasidoneNishan S. Gunasekara, Caroline M. Spencer, Gillian M. Keating · 2002
Polyethylene Glycol-Liposomal DoxorubicinMiriam Sharpe, Stephanie E. Easthope, Gillian M. Keating, Harriet M. Lamb · 2002
BasiliximabTherese M. Chapman, Gillian M. Keating · 2003
Budesonide/FormoterolNeil A. Reynolds, Caroline M. Perry, Gillian M. Keating · 2004
InfliximabDean M. Robinson, Gillian M. Keating · 2005
MicroRNA EpigeneticsBavan, Luckshman; Midwood, Kim; Nanchahal, Jagdeep · BioDrugs · 2011
Immunotherapy of Multiple SclerosisKarussis, Dimitrios · BioDrugs · 2013
RituximabAbdulla, Nihal E.; Ninan, Mary J.; Markowitz, Avi B. · BioDrugs · 2012
IpilimumabSanford, Mark · BioDrugs · 2012
Rotavirus VaccineBernstein, David I. · BioDrugs · 2000
Belimumab Therapy in Systemic Lupus ErythematosusZouali, Moncef; Uy, Eugene A. · BioDrugs · 2013
Strategies for Targeting Tetraspanin ProteinsHassuna, Noha; Monk, Peter N.; Moseley, Gregory W.; Partridge, Lynda J. · BioDrugs · 2009
MicroRNA-Based Therapeutics for CancerWang, Vivien; Wu, Wei · BioDrugs · 2009